How to Store PT-141 (Bremelanotide): Temperature, Shelf Life & Handling
Storage requirements for PT-141 (Bremelanotide) follow from what the molecule actually is — cyclic heptapeptide, melanocortin receptor agonist. The conditions below reflect that chemistry rather than generic peptide guidance.
In plain English
Freezer for the powder, fridge once mixed, two to four weeks, kept out of the light. It contains tryptophan, the most light-sensitive amino acid, so darkness is a genuine requirement rather than a precaution.
What PT-141 (Bremelanotide) actually is
PT-141 has an unusual history. It is a breakdown product of a compound originally developed for research into skin pigmentation, and an unexpected observation during that work redirected attention to the breakdown product, which was then developed as its own line of research.
Supplied for laboratory research use only — not for human or animal use.
Third-party tested by HPLC and LC-MS, ≥99% purity, with a Certificate of Analysis on every order. Ships across Canada.
Technical detail below
Storage conditions for PT-141 (Bremelanotide)
Why these conditions, specifically
Worth distinguishing from oxytocin: both are cyclic, but PT-141 closes through a lactam (an amide bond) rather than a disulfide. Amide bonds do not undergo the exchange and scrambling chemistry that dominates oxytocin degradation, so the cyclic structure here is a stability asset rather than a liability.
The main route to be aware of: tryptophan photo-oxidation — the main chemical route for this sequence.
All 3 degradation routes for PT-141 (Bremelanotide)Freeze–thaw
Aliquot on reconstitution. The lactam ring is chemically robust, so the constraints here are the usual oxidative and interfacial ones.
What PT-141 (Bremelanotide) is studied for
Acts at melanocortin receptors, with MC3R and MC4R the subtypes of research interest.
Distinguished in the literature by acting centrally, unlike vascular-mechanism compounds in adjacent research areas.
Its origin as a metabolite of a pigmentation-research compound is central to understanding its development history.
The lactam bridge restricts conformational freedom, a common strategy for improving receptor selectivity.
Summarizes published preclinical literature. Provided for research reference only; not a claim of efficacy or a description of human use.
More PT-141 (Bremelanotide) reference
Diluent selection, dissolution behaviour, and the calculator preset for this compound.
Which solvents work, why, and what abnormal dissolution behaviour indicates.
The specific chemical routes by which this molecule breaks down, and how to limit each.
Which assays are informative for this molecule, and what to actually check on its COA.
Compound-specific bench practices, and the errors most often made with this molecule.
What to inspect on arrival, and which conditions actually warrant rejecting a vial.
Questions specific to this compound — structure, chemistry, and common misconceptions.
Storage reference for other compounds
PT-141 (Bremelanotide) is supplied strictly as a research chemical for in-vitro laboratory and research use only. It is not intended for human or animal consumption, diagnostic, or therapeutic use. This page is educational laboratory-handling reference information — not medical advice, not usage guidance, and not a protocol.